Ozempic treatment depends on medical diagnosis, provider evaluation, insurance coverage, and prescription approval
At 3 years after drug initiation, of the 35,105 GLP-1 receptor agonist users, 14,910 (42.5%) had discontinued treatment, 18,481 (52.6%) had continued treatment and 1714 (4.9%) had died or emigrated (Fig
Possible Side Effects Some patients notice mild nausea, bloating, or constipation during the first few weeks
A fairer comparison would involve using equivalent amounts of dry leaves for both beverages
Continue working with your provider on a regular basis while taking any medication, including GLPs